Pharyngitis Treatment Market Size

Pharyngitis Treatment Market size was valued at USD 2.19 billion in 2023 and is projected to exceed USD 4.03 billion by the end of 2036, registering over 4.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pharyngitis treatment is evaluated at USD 2.27 billion.

The growth of the market can be attributed to the increasing cases of diseases that cause pharyngitis, such as, measles, whooping cough, and chickenpox, among others. According to the data by World Health Organization (WHO), in 2018, there were more than 140 000 deaths caused by measles, globally. Bacterial infection in the pharynx is the major cause of pharyngitis. The growing demand for treatment solution for the sore throat and pain, is estimated to boost the market growth. Moreover, increasing investment in developing measles vaccines, is also estimated to boost the market growth. As per other report by WHO, about 86% of the world's children received measles vaccines, in 2018. Between 2000-2018, use of vaccines prevented an estimate of 23.2 million deaths.